Cartilage-like scaffold to improve knee cartilage healing
A Novel Glycosaminoglycan Mimetic Scaffold for Cartilage Repair
This project is creating a cartilage-mimicking implant to help adults with knee cartilage damage heal better after microfracture surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia Univ New York Morningside NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11294340 on NIH RePORTER |
What this research studies
The researchers are designing a biomaterial scaffold that copies key sugar and protein features of developing cartilage to encourage the body's own cells to form healthy cartilage. They plan to combine the scaffold with microfracture surgery, which brings stem cells from the bone marrow into the cartilage defect. The scaffold is engineered to present specific glycosaminoglycan (GAG) patterns that help growth factors and cells make hyaline cartilage rather than scar-like fibrocartilage. Work will include lab testing of the material and its interactions with cells and tissues, with the aim of improving integration and long-term joint surface repair.
Who could benefit from this research
Good fit: Adults with symptomatic focal cartilage defects of the knee who are candidates for microfracture surgery would be the most likely candidates for this approach.
Not a fit: People with advanced generalized osteoarthritis, very large cartilage losses, inflammatory joint disease, or who are not surgical candidates are unlikely to benefit from this specific scaffold approach.
Why it matters
Potential benefit: If successful, this approach could produce more durable, cartilage-like repair tissue and reduce progression to osteoarthritis after focal knee cartilage injuries.
How similar studies have performed: Other scaffold and matrix-enhanced cartilage repair methods have shown mixed results in patients, and this specific GAG-mimetic scaffold represents a novel design that has not yet been proven clinically.
Where this research is happening
New York, United States
- Columbia Univ New York Morningside — New York, United States (Active)
Researchers
- Principal investigator: Arinzeh, Treena Lynne — Columbia Univ New York Morningside
- Study coordinator: Arinzeh, Treena Lynne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.